Group Pharmaceuticals Limited, a active public limited company, was established on 24 July 1980 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH1980PLC022889. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹12.68 Cr.
Formerly known as Group Pharmaceuticals Private Limited. It upholds a compliant status. Employing 739 professional, Its leadership includes Deepak Mohan (Managing Director), Sunil Attavar Cajaten (Nodal Officer), Ann Valerie Sunil Attavar (Whole-Time Director). Past directors included Deepak Mohan, Sunil Attavar Cajaten, Gopal Singh. It holds no open charges and ₹31.62 Cr settled loans. Its latest AGM occurred on 26 July 2025, with the balance sheet filed on 31 March 2025. It is based at W-46 (B) M I D Ctarapur Industrial Area, Thane, Maharashtra, 401506.
U24239MH1980PLC022889
022889
24 July 1980
₹25.00 Cr
₹12.68 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Group Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepak Mohan | Managing Director | 24 May 2024 | Current |
| Sunil Attavar Cajaten | Nodal Officer | 17 Sep 2019 | Current |
| Ann Valerie Sunil Attavar | Whole-Time Director | 15 Sep 2008 | Current |
| Srinivas Gogineni | Director | 08 Aug 2024 | Current |
| Nandipur Kallappa Dilip | Director | 08 Aug 2024 | Current |
| Jacob Mathew | Director | 24 May 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 07 Aug 2024 | Past |
| Pramod Abcsdd | Whole-Time Director | 15 Sep 2008 | Past |
| Pramod Abcsdd | Whole-Time Director | 24 May 2024 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2019 | Past |
| Pramod Abcsdd | Whole-Time Director | 10 Mar 2013 | Past |
| Pramod Abcsdd | Additional Director | 27 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Group Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 14.38% increase. The company also saw a substantial improvement in profitability, with a 120.66% increase in profit. The company's net worth Soared by an impressive increase of 19.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Group Pharmaceuticals had a promoter holding of 62.02% and a public holding of 37.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹316,165,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 2005 | Others | ₹16.25 Cr | Satisfied |
| 27 Mar 2002 | Central Bank Of India | ₹5.50 Cr | Satisfied |
| 04 Aug 2001 | Central Bank Of India | ₹0.00 | Satisfied |
| 12 Jul 1999 | Central Bank Of India | ₹0.00 | Satisfied |
| 16 Feb 1999 | Central Bank Of India | ₹0.00 | Satisfied |
Explore comprehensive loan charge details -
Group Pharmaceuticals has a workforce of 739 employees as of Mar 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Group Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Group Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nikhil Kaushik was appointed as a Additional Director was appointed as a Additional Director on 29 Sep 2025 & has been associated with this company since 1 month 25 days . was documented.
Group Pharmaceuticals Limited last Annual general meeting of members was held on 26 Jul 2025 as per latest MCA records. was recorded as a recent event.
Progress on Nikhil Kaushik was appointed as a Ceo was appointed as a Ceo on 28 May 2025 & has been associated with this company since 5 months 29 days . was documented.
Vineeth Gururaj Kulkarni was appointed as a Company Secretary was appointed as a Company Secretary on 28 May 2025 & has been associated with this company since 5 months 29 days . was recorded as a recent event.
Progress on Group Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
The activity Srinivas Gogineni was appointed as a Director was appointed as a Director on 08 Aug 2024 & has been associated with this company since 1 year 3 months . was completed.
The CIN of Group Pharmaceuticals Limited is U24239MH1980PLC022889.
Group Pharmaceuticals Limited is headquartered at W-46 (B) M I D Ctarapur Industrial Area, Thane, Maharashtra, 401506.
Group Pharmaceuticals Limited was incorporated on 24 July 1980.
The current directors of Group Pharmaceuticals Limited are
The primary industry of Group Pharmaceuticals Limited is Manufacturing.
Group Pharmaceuticals Limited is unlisted.
The authorized capital of Group Pharmaceuticals Limited is ₹25.00 Cr, and the paid-up capital is ₹12.68 Cr.
The compliance status of Group Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX